Cormorant Asset Management, LP Diversified Active

CIK: 0001583977 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value ($000): $1,449,259 (100.0% shares, 0.0% debt)

Holdings (36)

BBOT BRIDGEBIO ONCOLOGY THERAPEUT 14.3%
Value ($000) $207,034 Shares 17,878,594 Est. Cost $11.58 Unrealized
ABVX ABIVAX SA 11.4%
Value ($000) $165,555 Shares 1,950,000 Est. Cost $10.70 Unrealized
EYPT EYEPOINT PHARMACEUTICALS INC 8.2%
Value ($000) $118,548 Shares 8,325,000 Est. Cost $11.03 Unrealized +4.3%
RAPP RAPPORT THERAPEUTICS INC 6.5%
Value ($000) $94,818 Shares 3,192,521 Est. Cost $22.73 Unrealized -21.5%
BBIO BRIDGEBIO PHARMA INC 5.0%
Value ($000) $72,716 Shares 1,400,000 Est. Cost $20.96 Unrealized +132.7%
EWTX EDGEWISE THERAPEUTICS INC 4.5%
Value ($000) $65,042 Shares 4,010,000 Est. Cost $23.73 Unrealized -40.2%
DRUG BRIGHT MINDS BIOSCIENCES INC 4.4%
Value ($000) $64,259 Shares 1,059,331 Est. Cost $35.19 Unrealized +10.3%
ACLX ARCELLX INC 4.4%
Value ($000) $63,628 Shares 775,000 Est. Cost $25.75 Unrealized +179.6%
INSM INSMED INC 4.3%
Value ($000) $61,924 Shares 430,000 Est. Cost $37.15 Unrealized +229.8%
NAMS NEWAMSTERDAM PHARMA COMPANY 4.3%
Value ($000) $61,857 Shares 2,175,000 Est. Cost $20.31 Unrealized +18.0%
PRAX PRAXIS PRECISION MEDICINES I 3.7%
Value ($000) $53,000 Shares 1,000,000 Est. Cost $54.23 Unrealized -10.6%
CNTA CENTESSA PHARMACEUTICALS PLC 3.2%
Value ($000) $46,681 Shares 1,925,000 Est. Cost $13.13 Unrealized
PHVS PHARVARIS N V 2.3%
Value ($000) $34,012 Shares 1,363,200 Est. Cost $21.48 Unrealized +3.2%
CRBP CORBUS PHARMACEUTICALS HLDGS 2.1%
Value ($000) $30,044 Shares 2,375,000 Est. Cost $28.57 Unrealized -66.7%
GHRS GH RESEARCH PLC 1.9%
Value ($000) $27,405 Shares 1,916,439 Est. Cost $13.91 Unrealized +0.6%
CGON CG ONCOLOGY INC 1.7%
Value ($000) $25,175 Shares 625,000 Est. Cost $39.73 Unrealized -26.8%
KRRO KORRO BIO INC 1.5%
Value ($000) $22,269 Shares 465,000 Est. Cost $26.87 Unrealized -17.4%
MBX MBX BIOSCIENCES INC 1.5%
Value ($000) $21,438 Shares 1,225,000 Est. Cost $18.80 Unrealized -28.9%
METSERA INC 1.4%
Value ($000) $20,932 Shares 400,000 Est. Cost $27.22 Unrealized
JANX JANUX THERAPEUTICS INC 1.4%
Value ($000) $20,774 Shares 850,000 Est. Cost $40.93 Unrealized -40.5%
TARS TARSUS PHARMACEUTICALS INC 1.2%
Value ($000) $17,829 Shares 300,000 Est. Cost $21.36 Unrealized +130.5%
CRNX CRINETICS PHARMACEUTICALS IN 1.1%
Value ($000) $16,660 Shares 400,000 Est. Cost $24.75 Unrealized +29.2%
ENGN ENGENE HOLDINGS INC 1.1%
Value ($000) $15,870 Shares 2,323,595 Est. Cost $9.69 Unrealized -52.9%
ARQT ARCUTIS BIOTHERAPEUTICS INC 1.0%
Value ($000) $14,609 Shares 775,000 Est. Cost $7.71 Unrealized +104.5%
MLTX MOONLAKE IMMUNOTHERAPEUTICS 1.0%
Value ($000) $14,298 Shares 1,994,173 Est. Cost $12.22 Unrealized +326.5%
RNAM AVIDITY BIOSCIENCES INC 0.9%
Value ($000) $13,071 Shares 300,000 Est. Cost $38.44 Unrealized +5.2%
BIOA BIOAGE LABS INC 0.9%
Value ($000) $12,587 Shares 2,140,605 Est. Cost $18.97 Unrealized -75.3%
AXSM AXSOME THERAPEUTICS INC 0.8%
Value ($000) $12,145 Shares 100,000 Est. Cost $74.04 Unrealized +52.1%
CABA CABALETTA BIO INC 0.8%
Value ($000) $11,700 Shares 5,000,000 Est. Cost $1.56 Unrealized +10.0%
ORKA ORUKA THERAPEUTICS INC 0.7%
Value ($000) $10,256 Shares 533,340 Est. Cost $14.82 Unrealized 0.0%
ALMS ALUMIS INC 0.6%
Value ($000) $8,568 Shares 2,147,396 Est. Cost $13.30 Unrealized -69.0%
BMEA BIOMEA FUSION INC 0.5%
Value ($000) $7,213 Shares 3,570,872 Est. Cost $17.07 Unrealized -89.3%
AMLX AMYLYX PHARMACEUTICALS INC 0.5%
Value ($000) $6,795 Shares 500,000 Est. Cost $9.41 Unrealized 0.0%
PCVX VAXCYTE INC 0.4%
Value ($000) $6,304 Shares 175,000 Est. Cost $53.56 Unrealized -38.1%
ELVN ENLIVEN THERAPEUTICS INC 0.3%
Value ($000) $4,094 Shares 200,000 Est. Cost $25.92 Unrealized -22.2%
BHVN BIOHAVEN LTD 0.0%
Value ($000) $150 Shares 10,000 Est. Cost $43.60 Unrealized -66.6%